INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...
INOVIO submitted the BLA under the FDA's Accelerated Approval program and has requested a priority review ... an innovative DNA immunotherapy candidate that has the potential to become a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback